Drug Trial Radar · NCT02275910
Phase 1 Study of E7090 in Subjects With Solid Tumor
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Oct 28, 2014
Primary completion
Sep 3, 2021
Study completion Sep 3, 2021
Sponsor
- Lead sponsor
- Eisai Co., Ltd.Eisai
- Sponsor type
- Industry
- First posted
- Oct 27, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1 study of E7090 in subjects with advanced solid tumors. This study will be conducted in 2 parts: 1. Part 1 will be the dose escalation portion of this study to determine the maximum tolerated dose in subjects with solid tumors, and 2. Part 2 will comprise cohort expansions to further characterize the safety and tolerability of E7090 and to assess preliminary efficacy of E7090 in subjects with solid tumors characterized by genetic abnormalities in FGF/FGFR pathway.
Conditions
- Tumors
Interventions
E7090Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Number of Participants With Dose-limiting Toxicities (DLTs)Time frame: Cycle 0 (Cycle length= 7 days) up to Cycle 1 (Cycle length= 28 days)
- Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: From the start of study drug administration up to 2 year 9 months
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Eisai Trial Site #1
Chiba, Japan
Eisai Trial Site #1
Fukuoka, Japan
Eisai Trial Site #1
Kyoto, Japan
Eisai Trial Site #1
Osaka, Japan
Eisai Trial Site #2
Osaka, Japan
Eisai Trial Site #3
Osaka, Japan
Eisai Trial Site #1
Nagoya, Aichi-ken, Japan
Eisai Trial Site #1
Kashiwa, Chiba, Japan
Eisai Trial Site #1
Matsuyama, Ehime, Japan
Eisai Trial Site #1
Sapporo, Hokkaido, Japan
Eisai Trial Site #1
Amagasaki, Hyōgo, Japan
Eisai Trial Site #1
Tsukuba, Ibaraki, Japan
Eisai Trial Site #1
Kawasaki, Kanagawa, Japan
Eisai Trial Site #1
Yokohama, Kanagawa, Japan
Eisai Trial Site #1
Chuo-ku, Niigata, Japan
Eisai Trial Site #1
Kitaadachi, Saitama, Japan
Eisai Trial Site #1
Chuo-Ku, Tokyo, Japan
Eisai Trial Site #1
Koto-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.